Oppenheimer Emerging Markets Innovators Fund

N-CSRS 1 d178272dncsrs.htm OPPENHEIMER EMERGING MARKETS INNOVATORS FUND Oppenheimer Emerging Markets Innovators Fund

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT

INVESTMENT COMPANIES

Investment Company Act file number 811-22943

Oppenheimer Emerging Markets Innovators Fund

(Exact name of registrant as specified in charter)

6803 South Tucson Way, Centennial, Colorado 80112-3924

(Address of principal executive offices) (Zip code)

Cynthia Lo Bessette

OFI Global Asset Management, Inc.

225 Liberty Street, New York, New York 10281-1008

(Name and address of agent for service)

Registrant’s telephone number, including area code: (303) 768-3200

Date of fiscal year end: August 31

Date of reporting period: 2/29/2016

Item 1. Reports to Stockholders.

LOGO

Table of Contents



Fund Performance Discussion			3

Top Holdings and Allocations			7

Fund Expenses			10

Statement of Investments			12

Statement of Assets and Liabilities			16

Statement of Operations			18

Statements of Changes in Net Assets			19

Financial Highlights			20

Notes to Financial Statements			25

Board Approval of the Fund’s Investment Advisory and Sub-Advisory Agreements			39

Portfolio Proxy Voting Policies and Guidelines; Updates to Statement of Investments			42

Trustees and Officers			43

Privacy Policy Notice			44

Class A Shares

AVERAGE ANNUAL TOTAL RETURNS AT 2/29/16


	Class A Shares of the Fund
		Without Sales Charge	With Sales Charge	MSCI Emerging Markets Mid Cap Index
6-Month		-5.47%	-10.91%	-8.87%
1-Year		-13.38	-18.36	-21.93
Since Inception (6/30/14)		-13.99	-17.00	-16.38

Performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investment in the Fund will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Fund returns include changes in share price, reinvested distributions, and a 5.75% maximum applicable sales charge except where “without sales charge” is indicated. Current performance may be lower or higher than the performance quoted. Returns do not consider capital gains or income taxes on an individual’s investment. Returns for periods of less than one year are cumulative and not annualized. For performance data current to the most recent month-end, visit oppenheimerfunds.com or call 1.800.CALL OPP (225.5677).

2 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

Fund Performance Discussion

The Fund’s Class A shares (without sales charge) returned -5.47% during the six-month reporting period ended February 29, 2016. On a relative basis, the Fund outperformed the MSCI Emerging Markets Mid Cap Index (the “Index”), which returned -8.87%. Challenges related to the overall market continued to impact the Fund’s performance. Whether it was decelerating growth in China, commodity price declines, dramatic currency depreciations, or the U.S. Federal Reserve’s (“Fed”) decision to raise interest rates, there was no shortage of macroeconomic headlines during the reporting period. This made for a volatile time for emerging markets.

Relative to the Index, the Fund’s outperformance during this reporting stemmed primarily from stock selection in China and Malaysia. From a sector perspective, the Fund outperformed the Index in seven out of ten sectors, led by stock selection in consumer discretionary.

MARKET OVERVIEW

The six-month reporting period ended February 29, 2016 was a tumultuous time for global equity markets. The closing months of 2015 were marked by uncertainty over when or if the Fed would raise interest rates, which it eventually did in mid-December. Meanwhile, plummeting energy prices, decelerating emerging market growth and sluggish developed market growth combined to create an environment where investor sentiment swung back and forth like a pendulum. Market volatility picked up significantly in the beginning of 2016. The declines were largely the result of concerns surrounding growth in China and the continued drop in oil prices. Against this backdrop, emerging and developed market equities experienced losses.

FUND PERFORMANCE

Top contributors to absolute performance this reporting period included My EG Services Bhd., TAL Education Group and New Oriental Education & Technology Group, Inc.

My EG Services BHD (MYEG MK) is a Malaysian internet company that generates revenue by allowing customers to complete mandatory government forms online, including Foreign Worker Permit Renewals (FWPR). The stock soared nearly 57% in the fourth quarter of 2015 on the back of an announcement by the Malaysian government that it will no longer register foreign workers via its counters and that all FWPR filings must be completed via My EG’s online system. When a FWPR form is filed online, My EG collects a processing fee. To file a FWPR the employer must prove the foreign worker has health insurance, and My EG also acts as an online health insurance broker—its

3 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

commission for selling a healthcare policy is three times the processing fee. In the first half of 2015, My EG had 25% market share in FWPR filings. The recent government ruling has the potential to significantly benefit the company’s revenues for form processing and increase the volume of health insurance policies it sells. We believe My EG is run by very smart, innovative management who will find many ways to monetize its connection to the foreign worker population. We also believe it can generate additional sources of income by automating more government forms. My EG is the Fund’s largest holding at period end, accounting for roughly 3% of net assets.

Tal Education Group (XRS US) is a Chinese education company that specializes in math and sciences tutoring for the fast growing K-12 market. The penetration rate for tutoring services for K-12 in China is relatively low and the market is highly fragmented. We believe this provides the potential for rapid revenue growth over the next few years. Tal’s growth is further supported by the opportunity to significantly expand its geographic footprint. Overall we are bullish on education in China, believing these businesses are less cyclical than other consumer stocks because of parents’ strong aspirations for their children’s success.

New Oriental Education (EDU US) is an education company in China that specializes in English language tutoring and exam preparation. The company invested an impressive amount of money to embed

technology into its classrooms. We believe this investment will result in better testing outcomes for students and will differentiate EDU from its peers in the market for K-12 tutoring. Enthusiasm for the stock grew following the launch of its new online-to-offline service offering. As with Tal Education, EDU allows us to take advantage of the structural growth opportunities in the space.

Detractors from absolute performance this reporting period included Hermes Microvision, Inc., Cosmax, Inc. and Vipshop Holdings Ltd.

Hermes Microvision, Inc. (3658 TT) is a maker of electron beam inspection tools for semiconductor chip testing. As computer chip sizes shrink and the complexity of the chips increases, the defects in these chips become too tiny to detect with optical light. In this case, the only technology semiconductor makers can use is the shorter wavelength electron beams. The stock sold off significantly after chip maker Intel announced it would extend the time between its design node shrinks due to the expense and complexity of shrinking chip sizes. This move pushed out demand for Hermes Microvision E-Beam tools. We believe that semiconductor makers will continue to design more complex computer chips and expect revenues for Hermes Microvision to grow.

Cosmax (044820 KS) is a contract manufacturer of cosmetics for Korean, Chinese and multi-national cosmetics companies. World-class companies like L’Oreal and Johnson & Johnson are among

4 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

Cosmax’s nearly 150 clients. The stock suffered a sharp correction in February after the company reported disappointing results and concerns that the growth momentum for Chinese cosmetic brands was slowing. We believe this is a temporary situation and Cosmax is well-positioned to benefit from structural growth in consumer spending on cosmetics in China. Its reputation for high quality, particularly in China where Korean products enjoy premium pricing, makes Cosmax’s products highly marketable. We believe our focus-on-women theme is well represented in this and all our skincare investments.

VipShop (VIPS US) is China’s leading online discount retailer. It has created a unique market niche by offering customers deep-discount branded products via “flash sales.” Apparel, handbags and shoes account for >60% of products sold. VipShop’s business model is very clever. For most of its products it does not take inventory risk. Instead it offers retailers an avenue for inventory clearance, taking a cut of whatever is sold, delivering it for a fee and returning the unsold merchandise to the retailer. The stock sold off aggressively in November after its first ever quarterly profit miss and the market has yet to forgive it. Discount retailers usually outperform the broader consumer sector when spending slows. We are hopeful that 2016 will be a more profitable year for VipShop.

STRATEGY & OUTLOOK

The Fund was conceived with the thesis that an increasingly large number of attractive growth opportunities in the emerging markets are found among the small- and mid-cap universe, where they are often overlooked by investors who primarily focus on large-cap emerging market stocks, which dominate index funds and ETFs. Much of the growth is due to the talents of local entrepreneurs, so these opportunities are missed by investors who choose to access the emerging markets via U.S., Japanese or Western European companies that sell into the emerging markets.

We use innovation as a mental model to help identify companies that are creating differentiated businesses with long-term durable competitive advantages. “Innovation” in our context is a product, brand, business model or a strategic differentiation, that creates an entirely new market (this is what we call transformational innovation) or allows for rapid market share gains within an existing market.

Political, institutional and governance reforms have created perhaps the best backdrop for new business formations and growth than at any time in the history of the emerging markets. Despite some of the macro turbulence of late, things are generally better than they have ever been for a large swath of the roughly 6 billion people who live in most of the emerging and frontier markets. Affluence is broadly higher and skill levels in advanced fields like engineering and the

5 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

sciences are at an all-time high. Corporate governance standards and practices are improving. All of this feeds innovation and boosts aspirations. With this backdrop, businesses are increasingly able to move up the value-chain towards more complex, high-margin products and services.

We remain focused on identifying the innovators among a broad swath of emerging and frontier markets. Occasionally a seismic

macro event comes along, but most are temporal. Our view has always been that successful equity investing is best framed by a long-term focus on great businesses, not countries or currencies. We believe that great businesses invested in at sensible prices have the potential to produce superior investment results over the medium to long term. Despite the macro turbulence witnessed during the reporting period, we hold firm to this belief.

LOGO

Justin Leverenz, CFA

Portfolio Manager

LOGO

Heidi Heikenfeld, CFA

Portfolio Manager

6 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

Top Holdings and Allocations

TOP TEN GEOGRAPHICAL HOLDINGS


China	21.3	%
Taiwan	13.9
India	11.5
South Korea	11.3
United States	11.0
Malaysia	4.7
Mexico	4.1
Indonesia	4.1
Sri Lanka	1.8
Columbia	1.7

Portfolio holdings and allocation are subject to change. Percentages are as of February 29, 2016, and are based on total market value of investments.

TOP TEN COMMON STOCK HOLDINGS


My EG Services Bhd	3.0	%
Hota Industrial Manufacturing Co. Ltd.	2.7
Medy-Tox, Inc.	2.6
Bloomage BioTechnology Corp. Ltd.	2.5
TAL Education Group, ADR	2.4
Biocon Ltd.	1.9
Gentera SAB de CV	1.9
Amorepacific Corp.	1.7
New Oriental Education & Technology Group, Inc., Sponsored ADR	1.6
Alsea SAB de CV	1.6

Portfolio holdings and allocations are subject to change. Percentages are as of February 29, 2016, and are based on net assets. For more current Fund holdings, please visit oppenheimerfunds.com.

REGIONAL ALLOCATION

LOGO

Portfolio holdings and allocations are subject to change. Percentages are as of February 29, 2016, and are based on the total market value of investments.

7 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

Share Class Performance

AVERAGE ANNUAL TOTAL RETURNS WITHOUT SALES CHARGE AS OF 2/29/16


	Inception Date		6-Month			1-Year			Since Inception
Class A (EMIAX)		6/30/14		-5.47	%		-13.38	%		-13.99	%
Class C (EMVCX)		6/30/14		-5.77			-14.00			-14.64
Class I (EMVIX)		6/30/14		-5.21			-12.81			-13.53
Class R (EMIRX)		6/30/14		-5.49			-13.51			-14.17
Class Y (EMIYX)		6/30/14		-5.34			-13.04			-13.76
AVERAGE ANNUAL TOTAL RETURNS WITH SALES CHARGE AS OF 2/29/16
	Inception Date		6-Month			1-Year			Since Inception
Class A (EMIAX)		6/30/14		-10.91	%		-18.36	%		-17.00	%
Class C (EMVCX)		6/30/14		-6.71			-14.86			-14.64
Class I (EMVIX)		6/30/14		-5.21			-12.81			-13.53
Class R (EMIRX)		6/30/14		-5.49			-13.51			-14.17
Class Y (EMIYX)		6/30/14		-5.34			-13.04			-13.76

Performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investment in the Fund will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted. Returns do not consider capital gains or income taxes on an individual’s investment. For performance data current to the most recent month-end, visit oppenheimerfunds.com or call 1.800.CALL OPP (225.5677). Fund returns include changes in share price, reinvested distributions, and the applicable sales charge: for Class A shares, the current maximum initial sales charge of 5.75% and for Class C shares, the contingent deferred sales charge (“CDSC”) of 1% for the 1-year period. Prior to 7/1/14, Class R shares were named Class N shares. Beginning 7/1/14, new purchases of Class R shares will no longer be subject to a CDSC upon redemption (any CDSC will remain in effect for purchases prior to 7/1/14). Returns for periods of less than one year are cumulative and not annualized.

The Fund’s performance is compared to the performance of the MSCI Emerging Markets Mid Cap Index, which is designed to measure performance of mid-capitalization, global emerging market equities. The Index is unmanaged and cannot be purchased directly by investors. While index comparisons may be useful to provide a benchmark for the Fund’s performance, it must be noted that the Fund’s investments are not limited to the investments comprising the Index. Index performance includes reinvestment of income, but does not reflect transaction costs, fees, expenses or taxes. Index performance is shown for illustrative purposes only as a benchmark for the Fund’s performance, and does not predict or depict performance of the Fund. The Fund’s performance reflects the effects of the Fund’s business and operating expenses.

The Fund’s investment strategy and focus can change over time. The mention of specific fund holdings does not constitute a recommendation by OppenheimerFunds, Inc. or its affiliates.

8 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

Before investing in any of the Oppenheimer funds, investors should carefully consider a fund’s investment objectives, risks, charges and expenses. Fund prospectuses and summary prospectuses contain this and other information about the funds, and may be obtained by asking your financial advisor, visiting oppenheimerfunds.com, or calling 1.800.CALL OPP (225.5677). Read prospectuses and summary prospectuses carefully before investing.

Shares of Oppenheimer funds are not deposits or obligations of any bank, are not guaranteed by any bank, are not insured by the FDIC or any other agency, and involve investment risks, including the possible loss of the principal amount invested.

9 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

Fund Expenses

Fund Expenses. As a shareholder of the Fund, you incur two types of costs: (1) transaction costs, which may include sales charges (loads) on purchase payments and/or contingent deferred sales charges on redemptions; and (2) ongoing costs, including management fees; distribution and service fees; and other Fund expenses. These examples are intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

The examples are based on an investment of $1,000.00 invested at the beginning of the period and held for the entire 6-month period ended February 29, 2016.

Actual Expenses. The first section of the table provides information about actual account values and actual expenses. You may use the information in this section for the class of shares you hold, together with the amount you invested, to estimate the expense that you paid over the period. Simply divide your account value by $1,000.00 (for example, an $8,600.00 account value divided by $1,000.00 = 8.60), then multiply the result by the number in the first section under the heading entitled “Expenses Paid During 6 Months Ended February 29, 2016” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes. The second section of the table provides information about hypothetical account values and hypothetical expenses based on the Fund’s actual expense ratio for each class of shares, and an assumed rate of return of 5% per year for each class before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example for the class of shares you hold with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as front-end or contingent deferred sales charges (loads). Therefore, the “hypothetical” section of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

10 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND


Actual	Beginning Account Value September 1, 2015	Ending Account Value February 29, 2016	Expenses Paid During 6 Months Ended February 29, 2016
Class A	$ 1,000.00	$ 945.30	$ 8.26
Class C	1,000.00	942.30	12.00
Class I	1,000.00	947.90	6.07
Class R	1,000.00	945.10	9.62
Class Y	1,000.00	946.60	7.04

Hypothetical (5% return before expenses)
Class A	1,000.00	1,016.41	8.56
Class C	1,000.00	1,012.58	12.44
Class I	1,000.00	1,018.65	6.29
Class R	1,000.00	1,015.02	9.97
Class Y	1,000.00	1,017.65	7.30

Expenses are equal to the Fund’s annualized expense ratio for that class, multiplied by the average account value over the period, multiplied by 182/366 (to reflect the one-half year period). Those annualized expense ratios, excluding indirect expenses from affiliated funds, based on the 6-month period ended February 29, 2016 are as follows:


Class	Expense Ratios
Class A		1.70%
Class C		2.47
Class I		1.25
Class R		1.98
Class Y		1.45

The expense ratios reflect voluntary and/or contractual waivers and/or reimbursements of expenses by the Fund’s Manager. Some of these undertakings may be modified or terminated at any time, as indicated in the Fund’s prospectus. The “Financial Highlights” tables in the Fund’s financial statements, included in this report, also show the gross expense ratios, without such waivers or reimbursements and reduction to custodian expenses, if applicable.

11 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

STATEMENT OF INVESTMENTS February 29, 2016 Unaudited


	Shares		Value
Common Stocks—86.8%
Consumer Discretionary—26.6%
Auto Components—3.1%
Bharat Forge Ltd.		72,324	$	787,235
Hota Industrial Manufacturing Co. Ltd.		1,473,149		5,740,073
				6,527,308

Automobiles—0.7%
Brilliance China Automotive Holdings Ltd.		1,870,000		1,531,476

Diversified Consumer Services—6.2%
China Maple Leaf Educational Systems Ltd.		3,194,000		1,868,425
Fu Shou Yuan International Group Ltd.¹		3,648,000		2,784,082
New Oriental Education & Technology Group, Inc., Sponsored ADR		112,050		3,488,117
TAL Education Group, ADR²		99,860		5,167,755
				13,308,379

Hotels, Restaurants & Leisure—6.6%
Alsea SAB de CV		919,015		3,461,133
China Lodging Group Ltd., ADR		61,864		1,732,192
Genting Hong Kong Ltd.		1,987,000		625,845
Genting Malaysia Bhd		988,100		970,382
Homeinns Hotel Group, ADR²		48,220		1,680,467
Jollibee Foods Corp.		305,933		1,408,225
Mandarin Oriental International Ltd.		720,000		928,769
Minor International PCL		303,800		306,955
Syngene International Ltd.^2,3		512,218		2,934,966
				14,048,934

Household Durables—0.4%
Symphony Ltd.		30,433		874,371


	Shares		Value
Internet & Catalog Retail—1.2%
Vipshop Holdings Ltd., ADR²		222,250	$	2,469,197

Leisure Products—1.4%
KMC Kuei Meng International, Inc.		269,000		995,710
Merida Industry Co. Ltd.		431,000		1,966,975
				2,962,685

Media—0.5%
Global Mediacom Tbk PT		13,661,000		894,608
Smiles SA		39,000		282,821
				1,177,429

Specialty Retail—0.9%
JUMBO SA²		98,052		1,193,676
Shanghai La Chapelle Fashion Co. Ltd., Cl. H³		450,800		669,994
				1,863,670

Textiles, Apparel & Luxury Goods—5.6%
Arvind Ltd.		697,956		2,415,667
Cosmo Lady China Holdings Co. Ltd.³		2,224,000		1,871,117
Eclat Textile Co. Ltd.		169,000		2,117,678
Fila Korea Ltd.		20,479		1,549,209
HOSA International Ltd.		9,240,000		3,276,532
Page Industries Ltd.		4,689		680,237
				11,910,440

Consumer Staples—8.4%
Food & Staples Retailing—3.3%
Almacenes Exito SA		79,624		343,572
Big C Supercenter PCL		76,300		533,222
Jeronimo Martins SGPS SA		186,155		2,623,140
President Chain Store Corp.		262,000		1,769,406
Sumber Alfaria Trijaya Tbk PT		41,299,709		1,760,668
				7,030,008

Food Products—1.6%
Kaveri Seed Co. Ltd.		281,412		1,438,745
Standard Foods Corp.		715,000		1,779,303

12 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND


	Shares		Value
Food Products (Continued)
Vietnam Dairy Products JSC		30,000	$	172,607
				3,390,655

Personal Products—3.5%
Amorepacific Corp.		12,201		3,620,508
Cosmax, Inc.		15,333		1,528,583
Karex Bhd		2,556,900		2,377,253
				7,526,344

Financials—10.9%
Commercial Banks—6.0%
3SBio, Inc.^2,3		2,828,000		3,428,628
BGEO Group plc		81,554		2,243,114
Capitec Bank Holdings Ltd.		26,525		787,545
Commercial Bank of Ceylon plc		1,729,906		1,494,356
Commercial International Bank Egypt SAE		561,694		2,392,385
NUTRIBIOTECH Co. Ltd.²		42,263		1,943,896
Zenith Bank plc		8,988,764		500,158
				12,790,082

Consumer Finance—3.3%
Gentera SAB de CV		2,108,594		3,938,058
Shriram Transport Finance Co. Ltd.		254,185		2,970,849
				6,908,907

Diversified Financial Services—0.3%
Moscow Exchange (The)		518,222		683,370

Insurance—1.3%
Anadolu Hayat Emeklilik AS		499,974		925,848
Sanlam Ltd.		287,936		964,325
Sul America SA		224,900		898,917
				2,789,090

Real Estate Management & Development—0.0%
Belle Corp.		400		26

Health Care—13.1%
Biotechnology—6.1%
Biocon Ltd.		576,848		3,947,187
Medy-Tox, Inc.		15,352		5,516,066
Naturalendo Tech Co. Ltd.²		15,767		234,866
Seegene, Inc.²		80,287		2,196,110


	Shares		Value
Biotechnology (Continued)
Taiwan Liposome Co. Ltd.²		213,000	$	1,010,006
				12,904,235

Health Care Providers & Services—2.8%
Bumrungrad Hospital PCL		390,500		2,378,291
Odontoprev SA		408,100		1,031,543
Sinopharm Group Co. Ltd., Cl. H		714,800		2,600,760
				6,010,594

Pharmaceuticals—4.2%
Ajanta Pharma Ltd.		137,654		2,635,970
Aspen Pharmacare Holdings Ltd.²		75,573		1,331,848
Celltrion, Inc.²		37,122		3,008,914
Glenmark Pharmaceuticals Ltd.		171,265		1,843,093
Sihuan Pharmaceutical Holdings Group Ltd.		1,380,000		195,608
				9,015,433

Industrials—7.6%
Aerospace & Defense—0.4%
Embraer SA, Sponsored ADR		27,090		811,887

Air Freight & Couriers—0.8%
Kerry Logistics Network Ltd.		1,201,500		1,775,159

Commercial Services & Supplies—1.0%
KRUK SA		46,446		2,115,685

Industrial Conglomerates—1.0%
John Keells Holdings plc		1,996,289		2,197,911

Machinery—0.6%
Grupo Rotoplas SAB de CV²		779,730		1,230,451

Professional Services—1.1%
Sporton International, Inc.		437,000		2,428,149

Road & Rail—0.7%
Blue Bird Tbk PT		3,226,000		1,425,673

Trading Companies & Distributors—1.2%
Ace Hardware Indonesia Tbk PT		36,698,700		2,510,706

13 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

STATEMENT OF INVESTMENTS Unaudited / Continued


	Shares		Value
Transportation Infrastructure—0.8%
International Container Terminal Services, Inc.		1,280,250	$	1,668,537
Information Technology—14.8%
Electronic Equipment, Instruments, & Components—3.1%
AAC Technologies Holdings, Inc.		495,500		3,421,916
Largan Precision Co. Ltd.		41,000		3,082,827
				6,504,743

Internet Software & Services—1.8%
Autohome, Inc., ADR²		81,000		1,985,310
Kakao Corp.²		10,076		771,121
YY, Inc., ADR²		22,618		1,177,267
				3,933,698

IT Services—4.5%
Mindtree Ltd.		148,450		3,094,541
My EG Services Bhd		12,411,700		6,434,665
				9,529,206

Semiconductors & Semiconductor Equipment—2.6%
eMemory Technology, Inc.		328,000		3,443,089
Hermes Microvision, Inc.		89,000		2,178,102
				5,621,191

Software—1.6%
GOLFZON Co. Ltd.		9,588		554,679
NCSoft Corp.		14,465		2,804,164
				3,358,843

Technology Hardware, Storage & Peripherals—1.2%
Catcher Technology Co. Ltd.		335,000		2,612,914


	Shares		Value
Materials—5.4%
Chemicals—3.5%
Bloomage BioTechnology Corp. Ltd.		2,400,000	$	5,390,173
Fatima Fertilizer Co. Ltd.		6,105,001		2,115,734
				7,505,907

Construction Materials—1.9%
Cementos Argos SA		520,264		1,628,344
Indocement Tunggal Prakarsa Tbk PT		1,357,000		2,031,452
Shree Cement Ltd.		2,817		414,609
				4,074,405
Total Common Stocks (Cost $193,505,159)				185,027,698


Preferred Stock—0.8%
Banco Davivienda SA, Preference (Cost $2,579,852)		217,100		1,654,522


Investment Company—10.9%
Oppenheimer Institutional Money Market Fund, Cl. E, 0.42%^4,5(Cost $23,113,036)		23,113,036		23,113,036

Total Investments,at Value (Cost $219,198,047)		98.5%		209,795,256
Net Other Assets (Liabilities)		1.5		3,185,349
Net Assets		100.0%	$	212,980,605

Footnotes to Statement of Investments

1. Restricted security. The aggregate value of restricted securities at period end was $2,784,082, which represents 1.31% of the Fund’s net assets. See Note 4 of the accompanying Notes. Information concerning restricted securities is as follows:

Security

Acquisition

Dates

Cost

Value

Unrealized

Appreciation

Fu Shou Yuan International Group Ltd.

9/25/15-2/19/16

2,544,192

2,784,082

239,890

2. Non-income producing security.

14 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

Footnotes to Statement of Investments (Continued)

3. Represents securities sold under Rule 144A, which are exempt from registration under the Securities Act of 1933, as amended. These securities have been determined to be liquid under guidelines established by the Board of Trustees. These securities amount to $8,904,705 or 4.18% of the Fund’s net assets at period end.

4. Rate shown is the 7-day yield at period end.

5. Is or was an affiliate, as defined in the Investment Company Act of 1940, as amended, at or during the reporting period, by virtue of the Fund owning at least 5% of the voting securities of the issuer or as a result of the Fund and the issuer having the same investment adviser. Transactions during the reporting period in which the issuer was an affiliate are as follows:


	Shares August 31, 2015		Gross Additions		Gross Reductions		Shares February 29, 2016

Oppenheimer Institutional Money Market Fund, Cl. E		11,250,190		99,051,571		87,188,725		23,113,036

					Value		Income

Oppenheimer Institutional Money Market Fund, Cl. E					$	23,113,036	$	26,573

Distribution of investments representing geographic holdings, as a percentage of total investments at value, is as follows:


Geographic Holdings	Value		Percent

China	$	44,739,015		21.3%
Taiwan		29,124,232		13.9
India		24,037,469		11.5
South Korea		23,728,117		11.3
United States		23,113,036		11.0
Malaysia		9,782,300		4.7
Mexico		8,629,642		4.1
Indonesia		8,623,108		4.1
Sri Lanka		3,692,267		1.8
Colombia		3,626,439		1.7
Hong Kong		3,329,773		1.6
Thailand		3,218,468		1.5
South Africa		3,083,719		1.5
Philippines		3,076,787		1.5
Brazil		3,025,168		1.4
Portugal		2,623,140		1.3
Egypt		2,392,385		1.1
Georgia		2,243,114		1.1
Pakistan		2,115,734		1.0
Poland		2,115,685		1.0
Greece		1,193,676		0.6
Turkey		925,848		0.4
Russia		683,370		0.3
Nigeria		500,157		0.2
Vietnam		172,607		0.1

Total	$	209,795,256		100.0%

See accompanying Notes to Financial Statements.

15 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

STATEMENT OF ASSETS AND LIABILITIES February 29, 2016 Unaudited



Assets
Investments, at value—see accompanying statement of investments:
Unaffiliated companies (cost $196,085,011)	$	186,682,220
Affiliated companies (cost $23,113,036)		23,113,036

		209,795,256

Cash		772,007

Cash—foreign currencies (cost $985,504)		984,264

Receivables and other assets:
Shares of beneficial interest sold		2,867,679
Investments sold		139,328
Dividends		94,789
Other		33,827

Total assets		214,687,150


Liabilities
Payables and other liabilities:
Investments purchased		1,114,102
Shares of beneficial interest redeemed		474,890
Foreign capital gains tax		97,652
Distribution and service plan fees		13,777
Trustees’ compensation		1,305
Other		4,819

Total liabilities		1,706,545


Net Assets	$	212,980,605



Composition of Net Assets
Par value of shares of beneficial interest	$	27,355

Additional paid-in capital		246,081,251

Accumulated net investment loss		(773,466)

Accumulated net realized loss on investments and foreign currency transactions		(22,847,043)

Net unrealized depreciation on investments and translation of assets and liabilities denominated in foreign currencies		(9,507,492)

Net Assets	$	212,980,605

16 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND



Net Asset Value Per Share

Class A Shares:

Net asset value and redemption price per share (based on net assets of $54,667,310 and 7,032,246 shares of beneficial interest outstanding)	$	7.77

Maximum offering price per share (net asset value plus sales charge of 5.75% of offering price)	$	8.24


Class C Shares:

Net asset value, redemption price (excludes applicable contingent deferred sales charge) and offering price per share (based on net assets of $15,406,340 and 2,004,858 shares of beneficial interest outstanding)	$	7.68


Class I Shares:

Net asset value, redemption price and offering price per share (based on net assets of $116,436 and 14,876 shares of beneficial interest outstanding)	$	7.83


Class R Shares:

Net asset value, redemption price (excludes applicable contingent deferred sales charge) and offering price per share (based on net assets of $1,171,370 and 151,172 shares of beneficial interest outstanding)	$	7.75


Class Y Shares:

Net asset value, redemption price and offering price per share (based on net assets of $141,619,149 and 18,151,792 shares of beneficial interest outstanding)	$	7.80

See accompanying Notes to Financial Statements.

17 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

STATEMENT OF OPERATIONS For the Six Months Ended February 29, 2016



Investment Income
Dividends:
Unaffiliated companies (net of foreign withholding taxes of $49,801)	$	564,917
Affiliated companies		26,573

Interest		19

Total investment income		591,509


Expenses
Management fees		938,637

Distribution and service plan fees:
Class A		59,107
Class C		66,127
Class R		2,674

Transfer and shareholder servicing agent fees:
Class A		52,946
Class C		14,553
Class I		16
Class R		1,181
Class Y		110,765

Shareholder communications:
Class A		2,836
Class C		759
Class I		11
Class R		95
Class Y		3,485

Custodian fees and expenses		39,108

Trustees’ compensation		1,469

Borrowing fees		1,188

Other		46,450

Total expenses		1,341,407
Less reduction to custodian expenses		(114)
Less waivers and reimbursements of expenses		(19,320)

Net expenses		1,321,973


Net Investment Loss		(730,464)

Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investments from unaffiliated companies (net of foreign capital gains tax of $73,480)		(12,446,220)
Foreign currency transactions		(19,187)

Net realized loss		(12,465,407)

Net change in unrealized appreciation/depreciation on:
Investments		1,986,687
Translation of assets and liabilities denominated in foreign currencies		(912,711)

Net change in unrealized appreciation/depreciation		1,073,976


Net Decrease in Net Assets Resulting from Operations	$	(12,121,895)

See accompanying Notes to Financial Statements.

18 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

STATEMENTS OF CHANGES IN NET ASSETS


	Six Months Ended February 29, 2016 (Unaudited)		Year Ended August 31, 2015

Operations
Net investment loss	$	(730,464)	$	(143,034)

Net realized loss		(12,465,407)		(10,437,162)

Net change in unrealized appreciation/depreciation		1,073,976		(10,165,228)

Net decrease in net assets resulting from operations		(12,121,895)		(20,745,424)


Dividends and/or Distributions to Shareholders
Dividends from net investment income:
Class A		—		(63,182)
Class C		—		—
Class I		—		(20)
Class R		—		—
Class Y		—		(35,290)

		—		(98,492)

Distributions from net realized gain:
Class A		—		(37,110)
Class C		—		(3,002)
Class I		—		(5)
Class R		—		(175)
Class Y		—		(11,898)

		—		(52,190)


Beneficial Interest Transactions
Net increase (decrease) in net assets resulting from beneficial interest transactions:
Class A		15,840,953		(9,572,617)
Class C		5,520,294		9,438,897
Class I		20,000		111,258
Class R		271,713		970,033
Class Y		80,896,424		66,359,825

		102,549,384		67,307,396


Net Assets
Total increase		90,427,489		46,411,290

Beginning of period		122,553,116		76,141,826

End of period (including accumulated net investment loss of $773,466 and $43,002, respectively)	$	212,980,605	$	122,553,116

See accompanying Notes to Financial Statements.

19 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

FINANCIAL HIGHLIGHTS


Class A	Six Months Ended February 29, 2016 (Unaudited)		Year Ended August 31, 2015		Period Ended August 29, 2014^1,2

Per Share Operating Data
Net asset value, beginning of period		$8.22		$9.93		$10.00

Income (loss) from investment operations:
Net investment income (loss)³		(0.04)		(0.02)		0.02
Net realized and unrealized loss		(0.41)		(1.67)		(0.09)

Total from investment operations		(0.45)		(1.69)		(0.07)

Dividends and/or distributions to shareholders:
Dividends from net investment income		0.00		(0.01)		0.00
Distributions from net realized gain		0.00		(0.01)		0.00

Total dividends and/or distributions to shareholders		0.00		(0.02)		0.00

Net asset value, end of period		$7.77		$8.22		$9.93



Total Return, at Net Asset Value⁴		(5.47)%		(17.10)%		(0.70)%


Ratios/Supplemental Data
Net assets, end of period (in thousands)		$54,667		$41,993		$60,956

Average net assets (in thousands)		$48,501		$61,498		$56,084

Ratios to average net assets:⁵
Net investment income (loss)		(0.98)%		(0.21)%		1.37%
Expenses excluding interest and fees from borrowings		1.73%		1.71%		1.75%
Interest and fees from borrowings		0.00%⁶		0.00%⁶		0.00%

Total expenses		1.73%⁷		1.71%⁷		1.75%
Expenses after payments, waivers and/or reimbursements and reduction to custodian expenses		1.70%		1.70%		1.65%

Portfolio turnover rate		14%		34%		3%

1. For the period from June 30, 2014 (commencement of operations) to August 29, 2014.

2. August 29, 2014 represents the last business day of the Fund’s reporting period. See Note 2 of the accompanying Notes.

3. Per share amounts calculated based on the average shares outstanding during the period.

4. Assumes an initial investment on the business day before the first day of the fiscal period, with all dividends and distributions reinvested in additional shares on the reinvestment date, and redemption at the net asset value calculated on the last business day of the fiscal period. Sales charges are not reflected in the total returns. Total returns are not annualized for periods less than one full year. Returns do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares.

5. Annualized for periods less than one full year.

6. Less than 0.005%.

7. Total expenses including indirect expenses from affiliated fund fees and expenses were as follows:


Six Months Ended February 29, 2016	1.74	%
Year Ended August 31, 2015	1.72	%

See accompanying Notes to Financial Statements.

20 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND


Class C	Six Months Ended February 29, 2016 (Unaudited)		Year Ended August 31, 2015		Period Ended August 29, 2014^1,2

Per Share Operating Data
Net asset value, beginning of period		$8.16		$9.92		$10.00

Income (loss) from investment operations:
Net investment loss³		(0.07)		(0.08)		(0.00)⁴
Net realized and unrealized loss		(0.41)		(1.67)		(0.08)

Total from investment operations		(0.48)		(1.75)		(0.08)

Dividends and/or distributions to shareholders:
Dividends from net investment income		0.00		0.00		0.00
Distributions from net realized gain		0.00		(0.01)		0.00

Total dividends and/or distributions to shareholders		0.00		(0.01)		0.00

Net asset value, end of period		$7.68		$8.16		$9.92



Total Return, at Net Asset Value⁵		(5.77)%		(17.80)%		(0.80)%


Ratios/Supplemental Data
Net assets, end of period (in thousands)		$15,406		$10,795		$2,987

Average net assets (in thousands)		$13,338		$7,615		$1,591

Ratios to average net assets:⁶
Net investment loss		(1.74)%		(0.88)%		(0.31)%
Expenses excluding interest and fees from borrowings		2.48%		2.69%		2.56%
Interest and fees from borrowings		0.00%⁷		0.00%⁷		0.00%

Total expenses		2.48%⁸		2.69%⁸		2.56%
Expenses after payments, waivers and/or reimbursements and reduction to custodian expenses		2.47%		2.50%		2.42%

Portfolio turnover rate		14%		34%		3%

1. For the period from June 30, 2014 (commencement of operations) to August 29, 2014.

2. August 29, 2014 represents the last business day of the Fund’s reporting period. See Note 2 of the accompanying Notes.

3. Per share amounts calculated based on the average shares outstanding during the period.

4. Less than $0.005 per share.

5. Assumes an initial investment on the business day before the first day of the fiscal period, with all dividends and distributions reinvested in additional shares on the reinvestment date, and redemption at the net asset value calculated on the last business day of the fiscal period. Sales charges are not reflected in the total returns. Total returns are not annualized for periods less than one full year. Returns do not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares.

6. Annualized for periods less than one full year.

7. Less than 0.005%.

8. Total expenses including indirect expenses from affiliated fund fees and expenses were as follows:


Six Months Ended February 29, 2016	2.49	%
Year Ended August 31, 2015	2.70	%

See accompanying Notes to Financial Statements.

21 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

FINANCIAL HIGHLIGHTS Continued


Class I	Six Months Ended February 29, 2016 (Unaudited)		Year Ended August 31, 2015		Period Ended August 29, 2014^1,2

Per Share Operating Data
Net asset value, beginning of period		$8.26		$9.94		$10.00

Income (loss) from investment operations:
Net investment income (loss)³		(0.02)		0.05		0.03
Net realized and unrealized loss		(0.41)		(1.70)		(0.09)

Total from investment operations		(0.43)		(1.65)		(0.06)

Dividends and/or distributions to shareholders:
Dividends from net investment income		0.00		(0.02)		0.00
Distributions from net realized gain		0.00		(0.01)		0.00

Total dividends and/or distributions to shareholders		0.00		(0.03)		0.00

Net asset value, end of period		$7.83		$8.26		$9.94



Total Return, at Net Asset Value⁴		(5.21)%		(16.68)%		(0.60)%


Ratios/Supplemental Data
Net assets, end of period (in thousands)		$117		$102		$10

Average net assets (in thousands)		$110		$64		$11

Ratios to average net assets:⁵
Net investment income (loss)		(0.51)%		0.54%		1.58%
Expenses excluding interest and fees from borrowings		1.30%		1.60%		1.41%
Interest and fees from borrowings		0.00%⁶		0.00%⁶		0.00%

Total expenses		1.30%⁷		1.60%⁷		1.41%
Expenses after payments, waivers and/or reimbursements and reduction to custodian expenses		1.25%		1.25%		1.17%

Portfolio turnover rate		14%		34%		3%

1. For the period from June 30, 2014 (commencement of operations) to August 29, 2014.

2. August 29, 2014 represents the last business day of the Fund’s reporting period. See Note 2 of the accompanying Notes.

3. Per share amounts calculated based on the average shares outstanding during the period.

5. Annualized for periods less than one full year.

6. Less than 0.005%.

7. Total expenses including indirect expenses from affiliated fund fees and expenses were as follows:


Six Months Ended February 29, 2016	1.31	%
Year Ended August 31, 2015	1.61	%

See accompanying Notes to Financial Statements.

22 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND


Class R	Six Months Ended February 29, 2016 (Unaudited)		Year Ended August 31, 2015		Period Ended August 29, 2014^1,2

Per Share Operating Data
Net asset value, beginning of period		$8.20		$9.93		$10.00

Income (loss) from investment operations:
Net investment income (loss)³		(0.05)		(0.03)		0.00⁴
Net realized and unrealized loss		(0.40)		(1.69)		(0.07)

Total from investment operations		(0.45)		(1.72)		(0.07)

Dividends and/or distributions to shareholders:
Dividends from net investment income		0.00		0.00		0.00
Distributions from net realized gain		0.00		(0.01)		0.00

Total dividends and/or distributions to shareholders		0.00		(0.01)		0.00

Net asset value, end of period		$7.75		$8.20		$9.93



Total Return, at Net Asset Value⁵		(5.49)%		(17.38)%		(0.70)%


Ratios/Supplemental Data
Net assets, end of period (in thousands)		$1,172		$966		$127

Average net assets (in thousands)		$1,081		$555		$47

Ratios to average net assets:⁶
Net investment income (loss)		(1.24)%		(0.36)%		0.07%
Expenses excluding interest and fees from borrowings		1.99%		2.24%		2.05%
Interest and fees from borrowings		0.00%⁷		0.00%⁷		0.00%

Total expenses		1.99%⁸		2.24%⁸		2.05%
Expenses after payments, waivers and/or reimbursements and reduction to custodian expenses		1.98%		2.00%		1.93%

Portfolio turnover rate		14%		34%		3%

1. For the period from June 30, 2014 (commencement of operations) to August 29, 2014.

2. August 29, 2014 represents the last business day of the Fund’s reporting period. See Note 2 of the accompanying Notes.

3. Per share amounts calculated based on the average shares outstanding during the period.

4. Less than $0.005 per share.

6. Annualized for periods less than one full year.

7. Less than 0.005%.

8. Total expenses including indirect expenses from affiliated fund fees and expenses were as follows:


Six Months Ended February 29, 2016	2.00	%
Year Ended August 31, 2015	2.25	%

See accompanying Notes to Financial Statements.

23 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

FINANCIAL HIGHLIGHTS Continued


Class Y	Six Months Ended February 29, 2016 (Unaudited)		Year Ended August 31, 2015		Period Ended August 29, 2014^1,2

Per Share Operating Data
Net asset value, beginning of period		$8.24		$9.94		$10.00

Income (loss) from investment operations:
Net investment income (loss)³		(0.03)		0.01		0.01
Net realized and unrealized loss		(0.41)		(1.68)		(0.07)

Total from investment operations		(0.44)		(1.67)		(0.06)

Dividends and/or distributions to shareholders:
Dividends from net investment income		0.00		(0.02)		0.00
Distributions from net realized gain		0.00		(0.01)		0.00

Total dividends and/or distributions to shareholders		0.00		(0.03)		0.00

Net asset value, end of period		$7.80		$8.24		$9.94



Total Return, at Net Asset Value⁴		(5.34)%		(16.92)%		(0.60)%


Ratios/Supplemental Data
Net assets, end of period (in thousands)		$141,619		$68,697		$12,062

Average net assets (in thousands)		$101,910		$38,619		$6,734

Ratios to average net assets:⁵
Net investment income (loss)		(0.74)%		0.14%		0.38%
Expenses excluding interest and fees from borrowings		1.48%		1.72%		1.59%
Interest and fees from borrowings		0.00%⁶		0.00%⁶		0.00%

Total expenses		1.48%⁷		1.72%⁷		1.59%
Expenses after payments, waivers and/or reimbursements and reduction to custodian expenses		1.45%		1.45%		1.40%

Portfolio turnover rate		14%		34%		3%

1. For the period from June 30, 2014 (commencement of operations) to August 29, 2014.

2. August 29, 2014 represents the last business day of the Fund’s reporting period. See Note 2 of the accompanying Notes.

3. Per share amounts calculated based on the average shares outstanding during the period.

5. Annualized for periods less than one full year.

6. Less than 0.005%.

7. Total expenses including indirect expenses from affiliated fund fees and expenses were as follows:


Six Months Ended February 29, 2016	1.49	%
Year Ended August 31, 2015	1.73	%

See accompanying Notes to Financial Statements.

24 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

NOTES TO FINANCIAL STATEMENTS February 29, 2016 Unaudited

1. Organization

Oppenheimer Emerging Markets Innovators Fund (the “Fund”) is a diversified open-end management investment company registered under the Investment Company Act of 1940 (“1940 Act”), as amended. The Fund’s investment objective is to seek capital appreciation. The Fund’s investment adviser is OFI Global Asset Management, Inc. (“OFI Global” or the “Manager”), a wholly-owned subsidiary of OppenheimerFunds, Inc. (“OFI” or the “Sub-Adviser”). The Manager has entered into a sub-advisory agreement with OFI.

The Fund offers Class A, Class C, Class I, Class R and Class Y shares. As of July 1, 2014, Class N shares were renamed Class R shares. Class N shares subject to a contingent deferred sales charge (“CDSC”) on July 1, 2014, continue to be subject to a CDSC after the shares were renamed. Purchases of Class R shares occurring on or after July 1, 2014, are not subject to a CDSC upon redemption. Class A shares are sold at their offering price, which is normally net asset value plus a front-end sales charge. Class C and Class R shares are sold without a front-end sales charge but may be subject to a contingent deferred sales charge (“CDSC”). Class R shares are sold only through retirement plans. Retirement plans that offer Class R shares may impose charges on those accounts. Class I and Class Y shares are sold to certain institutional investors or intermediaries without either a front-end sales charge or a CDSC, however, the intermediaries may impose charges on their accountholders who beneficially own Class I and Class Y shares. All classes of shares have identical rights and voting privileges with respect to the Fund in general and exclusive voting rights on matters that affect that class alone. Earnings, net assets and net asset value per share may differ due to each class having its own expenses, such as transfer and shareholder servicing agent fees and shareholder communications, directly attributable to that class. Class A, C and R shares have separate distribution and/or service plans under which they pay fees. Class I and Class Y shares do not pay such fees.

The following is a summary of significant accounting policies followed in the Fund’s preparation of financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).

2. Significant Accounting Policies

Security Valuation. All investments in securities are recorded at their estimated fair value, as described in Note 3.

Reporting Period End Date. The last day of the Fund’s reporting period is the last day the New York Stock Exchange was open for trading during the period. The Fund’s financial statements have been presented through that date to maintain consistency with the Fund’s net asset value calculations used for shareholder transactions.

Foreign Currency Translation. The Fund’s accounting records are maintained in U.S. dollars. The values of securities denominated in foreign currencies and amounts related to the purchase and sale of foreign securities and foreign investment income are translated into U.S. dollars as of the close of the New York Stock Exchange (the “Exchange”), normally 4:00 P.M.

25 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

NOTES TO FINANCIAL STATEMENTS Unaudited / Continued

2. Significant Accounting Policies (Continued)

Eastern time, on each day the Exchange is open for trading. Foreign exchange rates may be valued primarily using a reliable bank, dealer or service authorized by the Board of Trustees.

Reported net realized gains and losses from foreign currency transactions arise from sales of portfolio securities, sales and maturities of short-term securities, sales of foreign currencies, exchange rate fluctuations between the trade and settlement dates on securities transactions, and the difference between the amounts of dividends, interest, and foreign withholding taxes recorded on the Fund’s books and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized appreciation and depreciation on the translation of assets and liabilities denominated in foreign currencies arise from changes in the values of assets and liabilities, including investments in securities at fiscal period end, resulting from changes in exchange rates.

The effect of changes in foreign currency exchange rates on investments is separately identified from the fluctuations arising from changes in market values of securities held and reported with all other foreign currency gains and losses in the Fund’s Statement of Operations.

Allocation of Income, Expenses, Gains and Losses. Income, expenses (other than those attributable to a specific class), gains and losses are allocated on a daily basis to each class of shares based upon the relative proportion of net assets represented by such class. Operating expenses directly attributable to a specific class are charged against the operations of that class.

Dividends and Distributions to Shareholders. Dividends and distributions to shareholders, which are determined in accordance with income tax regulations and may differ from U.S. GAAP, are recorded on the ex-dividend date. Income and capital gain distributions, if any, are declared and paid annually or at other times as deemed necessary by the Manager.

The tax character of distributions is determined as of the Fund’s fiscal year end. Therefore, a portion of the Fund’s distributions made to shareholders prior to the Fund’s fiscal year end may ultimately be categorized as a tax return of capital.

Investment Income. Dividend income is recorded on the ex-dividend date or upon ex-dividend notification in the case of certain foreign dividends where the ex-dividend date may have passed. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Interest income is recognized on an accrual basis. Discount and premium, which are included in interest income on the Statement of Operations, are amortized or accreted daily.

Custodian Fees. “Custodian fees and expenses” in the Statement of Operations may include interest expense incurred by the Fund on any cash overdrafts of its custodian account during the period. Such cash overdrafts may result from the effects of failed trades in portfolio securities and from cash outflows resulting from unanticipated shareholder redemption

26 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

2. Significant Accounting Policies (Continued)

activity. The Fund pays interest to its custodian on such cash overdrafts, to the extent they are not offset by positive cash balances maintained by the Fund, at a rate equal to the Federal Funds Rate plus 0.50%. The “Reduction to custodian expenses” line item, if applicable, represents earnings on cash balances maintained by the Fund during the period. Such interest expense and other custodian fees may be paid with these earnings.

Security Transactions. Security transactions are recorded on the trade date. Realized gains and losses on securities sold are determined on the basis of identified cost.

Indemnifications. The Fund’s organizational documents provide current and former Trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Fund. In the normal course of business, the Fund may also enter into contracts that provide general indemnifications. The Fund’s maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against the Fund. The risk of material loss from such claims is considered remote.

Federal Taxes. The Fund intends to comply with provisions of the Internal Revenue Code applicable to regulated investment companies and to distribute substantially all of its investment company taxable income to shareholders. Therefore, no federal income or excise tax provision is required. The Fund files income tax returns in U.S. federal and applicable state jurisdictions. The statute of limitations on the Fund’s tax return filings generally remains open for the three preceding fiscal reporting period ends. The Fund has analyzed its tax positions for the fiscal year ended August 31, 2015, including open tax years, and does not believe there are any uncertain tax positions requiring recognition in the Fund’s financial statements.

During the fiscal year ended August 31, 2015, the Fund did not utilize any capital loss carryforward to offset capital gains realized in that fiscal year. The Fund had post-October foreign currency losses of $22,953. Details of the fiscal year ended August 31, 2015 capital loss carryforwards are included in the table below. Capital loss carryforwards with no expiration, if any, must be utilized prior to those with expiration dates. Capital losses with no expiration will be carried forward to future years if not offset by gains.


Expiring
No expiration	$	10,320,161

At period end, it is estimated that the capital loss carryforwards would be $22,785,568, which will not expire. The estimated capital loss carryforward represents the carryforward as of the end of the last fiscal year, increased or decreased by capital losses or gains realized in the first six months of the current fiscal year. During the reporting period, it is estimated that the Fund will not utilize any capital loss carryforward to offset realized capital gains.

Net investment income (loss) and net realized gain (loss) may differ for financial statement and tax purposes. The character of dividends and distributions made during the fiscal year from net investment income or net realized gains are determined in accordance with federal

27 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

NOTES TO FINANCIAL STATEMENTS Unaudited / Continued

2. Significant Accounting Policies (Continued)

income tax requirements, which may differ from the character of net investment income or net realized gains presented in those financial statements in accordance with U.S. GAAP. Also, due to timing of dividends and distributions, the fiscal year in which amounts are distributed may differ from the fiscal year in which the income or net realized gain was recorded by the Fund.

The aggregate cost of securities and other investments and the composition of unrealized appreciation and depreciation of securities and other investments for federal income tax purposes at period end are noted in the following table. The primary difference between book and tax appreciation or depreciation of securities and other investments, if applicable, is attributable to the tax deferral of losses or tax realization of financial statement unrealized gain or loss.


Federal tax cost of securities	$	219,454,209

Gross unrealized appreciation	$	19,050,992
Gross unrealized depreciation		(28,715,753)

Net unrealized depreciation	$	(9,664,761)

Certain foreign countries impose a tax on capital gains which is accrued by the Fund based on unrealized appreciation, if any, on affected securities. The tax is paid when the gain is realized.

Use of Estimates. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.

3. Securities Valuation

The Fund calculates the net asset value of its shares as of the close of the New York Stock Exchange (the “Exchange”), normally 4:00 P.M. Eastern time, on each day the Exchange is open for trading, except in the case of a scheduled early closing of the Exchange, in which case the Fund will calculate net asset value of the shares as of the scheduled early closing time of the Exchange.

The Fund’s Board has adopted procedures for the valuation of the Fund’s securities and has delegated the day-to-day responsibility for valuation determinations under those procedures to the Manager. The Manager has established a Valuation Committee which is responsible for determining a “fair valuation” for any security for which market quotations are not “readily available.” The Valuation Committee’s fair valuation determinations are subject to review, approval and ratification by the Fund’s Board at its next regularly scheduled meeting covering the calendar quarter in which the fair valuation was determined.

Valuation Methods and Inputs

Securities are valued using unadjusted quoted market prices, when available, as supplied primarily by third party pricing services or dealers.

28 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

3. Securities Valuation (Continued)

The following methodologies are used to determine the market value or the fair value of the types of securities described below:

Securities traded on a registered U.S. securities exchange (including exchange-traded derivatives other than futures and futures options) are valued based on the last sale price of the security reported on the principal exchange on which it is traded, prior to the time when the Fund’s assets are valued. In the absence of a sale, the security is valued at the mean between the bid and asked price on the principal exchange or, if not available from the principal exchange, obtained from two dealers. If bid and asked prices are not available from either the exchange or two dealers, the security is valued by using one of the following methodologies (listed in order of priority): (1) a bid from the principal exchange, (2) the mean between the bid and asked price as provided by a single dealer, or (3) a bid from a single dealer. A security of a foreign issuer traded on a foreign exchange, but not listed on a registered U.S. securities exchange, is valued based on the last sale price on the principal exchange on which the security is traded, as identified by the third party pricing service used by the Manager, prior to the time when the Fund’s assets are valued. If the last sale price is unavailable, the security is valued at the most recent official closing price on the principal exchange on which it is traded. If the last sales price or official closing price for a foreign security is not available, the security is valued at the mean between the bid and asked price per the exchange or, if not available from the exchange, obtained from two dealers. If bid and asked prices are not available from either the exchange or two dealers, the security is valued by using one of the following methodologies (listed in order of priority): (1) a bid from the exchange, (2) the mean between the bid and asked price as provided by a single dealer, or (3) a bid from a single dealer.

Shares of a registered investment company that are not traded on an exchange are valued at that investment company’s net asset value per share.

Corporate and government debt securities (of U.S. or foreign issuers) and municipal debt securities, event-linked bonds, loans, mortgage-backed securities, collateralized mortgage obligations, and asset-backed securities are valued at the mean between the “bid” and “asked” prices utilizing evaluated prices obtained from third party pricing services or broker-dealers who may use matrix pricing methods to determine the evaluated prices.

Short-term money market type debt securities with a remaining maturity of sixty days or less are valued at cost adjusted by the amortization of discount or premium to maturity (amortized cost), which approximates market value. Short-term debt securities with a remaining maturity in excess of sixty days are valued at the mean between the “bid” and “asked” prices utilizing evaluated prices obtained from third party pricing services or broker-dealers.

A description of the standard inputs that may generally be considered by the third party pricing vendors in determining their evaluated prices is provided below.

29 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

NOTES TO FINANCIAL STATEMENTS Unaudited / Continued

3. Securities Valuation (Continued)


Security Type		Standard inputs generally considered by third-party pricing vendors
Corporate debt, government debt, municipal, mortgage- backed and asset-backed securities		Reported trade data, broker-dealer price quotations, benchmark yields, issuer spreads on comparable securities, the credit quality, yield, maturity, and other appropriate factors.
Loans		Information obtained from market participants regarding reported trade data and broker-dealer price quotations.
Event-linked bonds		Information obtained from market participants regarding reported trade data and broker-dealer price quotations.

If a market value or price cannot be determined for a security using the methodologies described above, or if, in the “good faith” opinion of the Manager, the market value or price obtained does not constitute a “readily available market quotation,” or a significant event has occurred that would materially affect the value of the security, the security is fair valued either (i) by a standardized fair valuation methodology applicable to the security type or the significant event as previously approved by the Valuation Committee and the Fund’s Board or (ii) as determined in good faith by the Manager’s Valuation Committee. The Valuation Committee considers all relevant facts that are reasonably available, through either public information or information available to the Manager, when determining the fair value of a security. Fair value determinations by the Manager are subject to review, approval and ratification by the Fund’s Board at its next regularly scheduled meeting covering the calendar quarter in which the fair valuation was determined. Those fair valuation standardized methodologies include, but are not limited to, valuing securities at the last sale price or initially at cost and subsequently adjusting the value based on: changes in company specific fundamentals, changes in an appropriate securities index, or changes in the value of similar securities which may be further adjusted for any discounts related to security-specific resale restrictions. When possible, such methodologies use observable market inputs such as unadjusted quoted prices of similar securities, observable interest rates, currency rates and yield curves. The methodologies used for valuing securities are not necessarily an indication of the risks associated with investing in those securities nor can it be assured that the Fund can obtain the fair value assigned to a security if it were to sell the security.

To assess the continuing appropriateness of security valuations, the Manager, or its third party service provider who is subject to oversight by the Manager, regularly compares prior day prices, prices on comparable securities, and sale prices to the current day prices and challenges those prices exceeding certain tolerance levels with the third party pricing service or broker source. For those securities valued by fair valuations, whether through a standardized fair valuation methodology or a fair valuation determination, the Valuation Committee reviews and affirms the reasonableness of the valuations based on such methodologies and fair valuation determinations on a regular basis after considering all relevant information that is reasonably available.

Classifications

Each investment asset or liability of the Fund is assigned a level at measurement date based

30 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

3. Securities Valuation (Continued)

on the significance and source of the inputs to its valuation. Various data inputs are used in determining the value of each of the Fund’s investments as of the reporting period end. These data inputs are categorized in the following hierarchy under applicable financial accounting standards:

1) Level 1-unadjusted quoted prices in active markets for identical assets or liabilities (including securities actively traded on a securities exchange)

2) Level 2-inputs other than unadjusted quoted prices that are observable for the asset or liability (such as unadjusted quoted prices for similar assets and market corroborated inputs such as interest rates, prepayment speeds, credit risks, etc.)

3) Level 3-significant unobservable inputs (including the Manager’s own judgments about assumptions that market participants would use in pricing the asset or liability).

The inputs used for valuing securities are not necessarily an indication of the risks associated with investing in those securities.

The table below categorizes amounts that are included in the Fund’s Statement of Assets and Liabilities at period end based on valuation input level:


					Level 3—
	Level 1—		Level 2—		Significant
	Unadjusted		Other Significant		Unobservable
	Quoted Prices		Observable Inputs		Inputs		Value

Assets Table
Investments, at Value:
Common Stocks
Consumer Discretionary	$	14,537,728	$	42,136,161	$	—	$	56,673,889
Consumer Staples		—		17,947,007		—		17,947,007
Financials		26		23,171,449		—		23,171,475
Health Care		—		27,734,654		195,608		27,930,262
Industrials		2,480,424		13,683,734		—		16,164,158
Information Technology		3,162,577		28,398,018		—		31,560,595
Materials		—		11,580,312		—		11,580,312
Preferred Stock		—		1,654,522		—		1,654,522
Investment Company		23,113,036		—		—		23,113,036

Total Assets	$	43,293,791	$	166,305,857	$	195,608	$	209,795,256

Forward currency exchange contracts and futures contracts, if any, are reported at their unrealized appreciation/depreciation at measurement date, which represents the change in the contract’s value from trade date. All additional assets and liabilities included in the above table are reported at their market value at measurement date.

The table below shows the transfers between Level 1 and Level 2. The Fund’s policy is to recognize transfers in and transfers out as of the beginning of the reporting period.

31 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

NOTES TO FINANCIAL STATEMENTS Unaudited / Continued

3. Securities Valuation (Continued)


	Transfers into		Transfers out		Transfers into		Transfers out of
	Level 1*		of Level 1**		Level 2**		Level 2*

Assets Table
Investments, at Value:
Common Stocks
Consumer
Discretionary	$	–	$	(2,358,846)	$	2,358,846	$	–
Consumer
Staples		–		(187,104)		187,104		–
Financials		1,226,407		(4,550,928)		4,550,928		(1,226,407)
Health Care		–		(621,051)		621,051		–
Industrials		1,133,573		(448,782)		448,782		(1,133,573)
Materials		–		(1,326,252)		1,326,252		–
Preferred Stocks		–		(1,333,810)		1,333,810		–

Total Assets	$	2,359,980	$	(10,826,773)	$	10,826,773	$	(2,359,980)

* Transfers from Level 2 to Level 1 are a result of the availability of quoted prices from an active market which were not available and have become available.

** Transfers from Level 1 to Level 2 are a result of a change from the use of an exchange traded price to a valuation received from a third-party pricing service or a fair valuation determined based on observable market information other than quoted prices from an active market.

4. Investments and Risks

Risks of Foreign Investing. The Fund may invest in foreign securities which are subject to special risks. Securities traded in foreign markets may be less liquid and more volatile than those traded in U.S. markets. Foreign issuers are usually not subject to the same accounting and disclosure requirements that U.S. companies are subject to, which may make it difficult for the Fund to evaluate a foreign company’s operations or financial condition. A change in the value of a foreign currency against the U.S. dollar will result in a change in the U.S. dollar value of investments denominated in that foreign currency and in the value of any income or distributions the Fund may receive on those investments. The value of foreign investments may be affected by exchange control regulations, foreign taxes, higher transaction and other costs, delays in the settlement of transactions, changes in economic or monetary policy in the United States or abroad, expropriation or nationalization of a company’s assets, or other political and economic factors. In addition, due to the inter-relationship of global economies and financial markets, changes in political and economic factors in one country or region could adversely affect conditions in another country or region. Investments in foreign securities may also expose the Fund to time-zone arbitrage risk. Foreign securities may trade on weekends or other days when the Fund does not price its shares. At times, the Fund may emphasize investments in a particular country or region and may be subject to greater risks from adverse events that occur in that country or region. Foreign securities and foreign currencies held in foreign banks and securities depositories may be subject to limited or no regulatory oversight.

Investments in Affiliated Funds. The Fund is permitted to invest in other mutual funds advised by the Manager (“Affiliated Funds”). Affiliated Funds are open-end management

32 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

4. Investments and Risks (Continued)

investment companies registered under the 1940 Act, as amended. The Manager is the investment adviser of, and the Sub-Adviser provides investment and related advisory services to, the Affiliated Funds. When applicable, the Fund’s investments in Affiliated Funds are included in the Statement of Investments. Shares of Affiliated Funds are valued at their net asset value per share. As a shareholder, the Fund is subject to its proportional share of the Affiliated Funds’ expenses, including their management fee. The Manager will waive fees and/ or reimburse Fund expenses in an amount equal to the indirect management fees incurred through the Fund’s investment in the Affiliated Funds.

Each of the Affiliated Funds in which the Fund invests has its own investment risks, and those risks can affect the value of the Fund’s investments and therefore the value of the Fund’s shares. To the extent that the Fund invests more of its assets in one Affiliated Fund than in another, the Fund will have greater exposure to the risks of that Affiliated Fund.

Investment in Oppenheimer Institutional Money Market Fund. The Fund is permitted to invest daily available cash balances in a money market Affiliated Fund. The Fund may invest the available cash in Class E shares of Oppenheimer Institutional Money Market Fund (“IMMF”) to seek current income while preserving liquidity or for defensive purposes. IMMF is regulated as a money market fund under the Investment Company Act of 1940, as amended.

Restricted Securities. At period end, investments in securities included issues that are restricted. A restricted security may have a contractual restriction on its resale and is valued under methods approved by the Board of Trustees as reflecting fair value. Securities that are restricted are marked with an applicable footnote on the Statement of Investments. Restricted securities are reported on a schedule following the Statement of Investments.

Equity Security Risk. Stocks and other equity securities fluctuate in price. The value of the Fund’s portfolio may be affected by changes in the equity markets generally. Equity markets may experience significant short-term volatility and may fall sharply at times. Different markets may behave differently from each other and U.S. equity markets may move in the opposite direction from one or more foreign stock markets. Adverse events in any part of the equity or fixed-income markets may have unexpected negative effects on other market segments.

The prices of individual equity securities generally do not all move in the same direction at the same time and a variety of factors can affect the price of a particular company’s securities. These factors may include, but are not limited to, poor earnings reports, a loss of customers, litigation against the company, general unfavorable performance of the company’s sector or industry, or changes in government regulations affecting the company or its industry.

5. Market Risk Factors

The Fund’s investments in securities and/or financial derivatives may expose the fund to various market risk factors:

Commodity Risk. Commodity risk relates to the change in value of commodities or

33 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

NOTES TO FINANCIAL STATEMENTS Unaudited / Continued

5. Market Risk Factors (Continued)

commodity indexes as they relate to increases or decreases in the commodities market. Commodities are physical assets that have tangible properties. Examples of these types of assets are crude oil, heating oil, metals, livestock, and agricultural products.

Credit Risk. Credit risk relates to the ability of the issuer of debt to meet interest and principal payments, or both, as they come due. In general, lower-grade, higher-yield debt securities are subject to credit risk to a greater extent than lower-yield, higher-quality securities.

Equity Risk. Equity risk relates to the change in value of equity securities as they relate to increases or decreases in the general market.

Foreign Exchange Rate Risk. Foreign exchange rate risk relates to the change in the U.S. dollar value of a security held that is denominated in a foreign currency. The U.S. dollar value of a foreign currency denominated security will decrease as the dollar appreciates against the currency, while the U.S. dollar value will increase as the dollar depreciates against the currency.

Interest Rate Risk. Interest rate risk refers to the fluctuations in value of fixed-income securities resulting from the inverse relationship between price and yield. For example, an increase in general interest rates will tend to reduce the market value of already issued fixed-income investments, and a decline in general interest rates will tend to increase their value. In addition, debt securities with longer maturities, which tend to have higher yields, are subject to potentially greater fluctuations in value from changes in interest rates than obligations with shorter maturities.

Volatility Risk. Volatility risk refers to the magnitude of the movement, but not the direction of the movement, in a financial instrument’s price over a defined time period. Large increases or decreases in a financial instrument’s price over a relative time period typically indicate greater volatility risk, while small increases or decreases in its price typically indicate lower volatility risk.

6. Shares of Beneficial Interest

The Fund has authorized an unlimited number of $0.001 par value shares of beneficial interest of each class. Transactions in shares of beneficial interest were as follows:


	Six Months Ended February 29, 2016						Year Ended August 31, 2015
	Shares			Amount			Shares			Amount

Class A
Sold		3,651,319		$	29,689,718			5,862,731		$	53,952,731
Dividends and/or distributions reinvested		—			—			3,470			31,616
Redeemed		(1,728,541	)		(13,848,765	)		(6,892,881	)		(63,556,964)

Net increase (decrease)		1,922,778		$	15,840,953			(1,026,680	)	$	(9,572,617)

34 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

6. Shares of Beneficial Interest (Continued)


	Six Months Ended February 29, 2016				Year Ended August 31, 2015
	Shares		Amount		Shares		Amount

Class C
Sold		954,955	$	7,716,422		1,248,874	$	11,489,113
Dividends and/or distributions reinvested		—		—		329		2,992
Redeemed		(273,722)		(2,196,128)		(226,624)		(2,053,208)

Net increase		681,233	$	5,520,294		1,022,579	$	9,438,897



Class I
Sold		6,721	$	53,806		17,900	$	169,134
Dividends and/or distributions reinvested		—		—		—		—
Redeemed		(4,171)		(33,806)		(6,574)		(57,876)

Net increase		2,550	$	20,000		11,326	$	111,258



Class R
Sold		40,746	$	331,325		162,253	$	1,492,893
Dividends and/or distributions reinvested		—		—		18		166
Redeemed		(7,368)		(59,612)		(57,210)		(523,026)

Net increase		33,378	$	271,713		105,061	$	970,033



Class Y
Sold		13,543,303	$	110,712,816		9,816,759	$	89,670,514
Dividends and/or distributions reinvested		—		—		5,178		47,169
Redeemed		(3,729,593)		(29,816,392)		(2,697,486)		(23,357,858)

Net increase		9,813,710	$	80,896,424		7,124,451	$	66,359,825

7. Purchases and Sales of Securities

The aggregate cost of purchases and proceeds from sales of securities, other than short-term obligations and investments in IMMF, for the reporting period were as follows:


	Purchases		Sales
Investment securities		$111,293,661		$21,305,059

8. Fees and Other Transactions with Affiliates

Management Fees. Under the investment advisory agreement, the Fund pays the Manager a management fee based on the daily net assets of the Fund at an annual rate as shown in the following table:


Fee Schedule
Up to $500 million		1.15%
Next $500 million		1.10
Next $4 billion		1.05
Over $5 billion		1.00

The Fund’s effective management fee for the reporting period was 1.14% of average annual net assets before any applicable waivers.

35 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

NOTES TO FINANCIAL STATEMENTS Unaudited / Continued

8. Fees and Other Transactions with Affiliates (Continued)

Sub-Adviser Fees. The Manager has retained the Sub-Adviser to provide the day-to-day portfolio management of the Fund. Under the Sub-Advisory Agreement, the Manager pays the Sub-Adviser an annual fee in monthly installments, equal to a percentage of the investment management fee collected by the Manager from the Fund, which shall be calculated after any investment management fee waivers. The fee paid to the Sub-Adviser is paid by the Manager, not by the Fund.

Transfer Agent Fees. OFI Global (the “Transfer Agent”) serves as the transfer and shareholder servicing agent for the Fund. The Fund pays the Transfer Agent a fee based on annual net assets. Fees incurred and average net assets for each class with respect to these services are detailed in the Statement of Operations and Financial Highlights, respectively.

Sub-Transfer Agent Fees. The Transfer Agent has retained Shareholder Services, Inc., a wholly-owned subsidiary of OFI (the “Sub-Transfer Agent”), to provide the day-to-day transfer agent and shareholder servicing of the Fund. Under the Sub-Transfer Agency Agreement, the Transfer Agent pays the Sub-Transfer Agent an annual fee in monthly installments, equal to a percentage of the transfer agent fee collected by the Transfer Agent from the Fund, which shall be calculated after any applicable fee waivers. The fee paid to the Sub-Transfer Agent is paid by the Transfer Agent, not by the Fund.

Trustees’ Compensation. The Fund’s Board of Trustees (“Board”) has adopted a compensation deferral plan for Independent Trustees that enables Trustees to elect to defer receipt of all or a portion of the annual compensation they are entitled to receive from the Fund. For purposes of determining the amount owed to the Trustees under the plan, deferred amounts are treated as though equal dollar amounts had been invested in shares of the Fund or in other Oppenheimer funds selected by the Trustees. The Fund purchases shares of the funds selected for deferral by the Trustees in amounts equal to his or her deemed investment, resulting in a Fund asset equal to the deferred compensation liability. Such assets are included as a component of “Other” within the asset section of the Statement of Assets and Liabilities. Deferral of Trustees’ fees under the plan will not affect the net assets of the Fund and will not materially affect the Fund’s assets, liabilities or net investment income per share. Amounts will be deferred until distributed in accordance with the compensation deferral plan.

Distribution and Service Plan (12b-1) Fees. Under its General Distributor’s Agreement with the Fund, OppenheimerFunds Distributor, Inc. (the “Distributor”) acts as the Fund’s principal underwriter in the continuous public offering of the Fund’s classes of shares.

Service Plan for Class A Shares. The Fund has adopted a Service Plan (the “Plan”) for Class A shares pursuant to Rule 12b-1 under the 1940 Act. Under the Plan, the Fund reimburses the Distributor for a portion of its costs incurred for services provided to accounts that hold Class A shares. Reimbursement is made periodically at an annual rate of up to 0.25% of the daily net assets of Class A shares of the Fund. The Distributor currently uses all

36 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

8. Fees and Other Transactions with Affiliates (Continued)

of those fees to pay dealers, brokers, banks and other financial institutions periodically for providing personal service and maintenance of accounts of their customers that hold Class A shares. Any unreimbursed expenses the Distributor incurs with respect to Class A shares in any fiscal year cannot be recovered in subsequent periods. Fees incurred by the Fund under the Plan are detailed in the Statement of Operations.

Distribution and Service Plans for Class C and Class R Shares. The Fund has adopted Distribution and Service Plans (the “Plans”) for Class C and Class R shares pursuant to Rule 12b-1 under the 1940 Act to compensate the Distributor for distributing those share classes, maintaining accounts and providing shareholder services. Under the Plans, the Fund pays the Distributor an annual asset-based sales charge of 0.75% on Class C shares’ daily net assets and 0.25% on Class R shares’ daily net assets. The Fund also pays a service fee under the Plans at an annual rate of 0.25% of daily net assets. The Plans continue in effect from year to year only if the Fund’s Board of Trustees votes annually to approve their continuance at an in person meeting called for that purpose. Fees incurred by the Fund under the Plans are detailed in the Statement of Operations.

Sales Charges. Front-end sales charges and CDSC do not represent expenses of the Fund. They are deducted from the proceeds of sales of Fund shares prior to investment or from redemption proceeds prior to remittance, as applicable. The sales charges retained by the Distributor from the sale of shares and the CDSC retained by the Distributor on the redemption of shares is shown in the following table for the period indicated.

Class A

Class C

Class A

Contingent

Front-End

Deferred

Sales Charges

Retained by

Six Months Ended

Distributor

February 29, 2016

$18,423

$—

$3,878

Waivers and Reimbursements of Expenses. The Manager has contractually agreed to waive fees and/or reimburse expenses to limit the Fund’s “Expenses after payments, waivers and/or reimbursements and reduction to custodian expenses” (excluding any applicable dividend expense, taxes, interest and fees from borrowing, any subsidiary expenses, Acquired Fund Fees and Expenses, brokerage commissions, extraordinary expenses, interest and fees from borrowing, and certain other Fund expenses) so that, as percentages of average daily net assets, those expenses will not exceed the annual rate of 1.70% for Class A shares, 2.50% for Class C shares, 1.25% for Class I shares, 2.00% for Class R shares and 1.45% for Class Y shares. During the reporting period, the Manager waived $2,742, $16, and $6,953 for Class A, Class I and Class Y shares, respectively.

The Manager will waive fees and/or reimburse Fund expenses in an amount equal to the indirect management fees incurred through the Fund’s investment in IMMF. During the reporting period, the Manager waived fees and/or reimbursed the Fund $9,609 for IMMF

37 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

NOTES TO FINANCIAL STATEMENTS Unaudited / Continued

8. Fees and Other Transactions with Affiliates (Continued)

management fees.

Waivers and/or reimbursements may be modified or terminated as set forth according to the terms in the prospectus.

9. Borrowings and Other Financing

Joint Credit Facility. A number of mutual funds managed by the Manager participate in a $1.28 billion revolving credit facility (the “Facility”) intended to provide short-term financing, if necessary, subject to certain restrictions in connection with atypical redemption activity. Expenses and fees related to the Facility are paid by the participating funds and are disclosed separately or as other expenses on the Statement of Operations.

10. Pending Litigation

In 2009, several putative class action lawsuits were filed and later consolidated before the U.S. District Court for the District of Colorado against OppenheimerFunds, Inc. (“OFI”), OppenheimerFunds Distributor, Inc. (“OFDI”), and Oppenheimer Rochester California Municipal Fund, a fund advised by OFI Global Asset Management, Inc. and distributed by the Distributor (the “California Fund”), in connection with the California Fund’s investment performance. The plaintiffs asserted claims against OFI, OFDI and certain present and former trustees and officers of the California Fund under the federal securities laws, alleging, among other things, that the disclosure documents of the California Fund contained misrepresentations and omissions and the investment policies of the California Fund were not followed. Plaintiffs in the suit filed an amended complaint and defendants filed a motion to dismiss. In 2011, the court issued an order which granted in part and denied in part the defendants’ motion to dismiss. In 2012, plaintiffs filed a motion, which defendants opposed, to certify a class and appoint class representatives and class counsel. In March 2015, the court granted plaintiffs’ motion for class certification. In May 2015, the U.S. Court of Appeals for the Tenth Circuit vacated the class certification order and remanded the matter to the district court for further proceedings. In October 2015, the district court reaffirmed its order and determined that the suit will proceed as a class action. In December 2015, the Tenth Circuit denied defendants’ petition to appeal the district court’s reaffirmed class certification order.

OFI and OFDI believe the suit is without merit; that it is premature to render any opinion as to the likelihood of an outcome unfavorable to them in the suit; and that no estimate can yet be made as to the amount or range of any potential loss. Furthermore, OFI believes that the suit should not impair the ability of OFI or OFDI to perform their respective duties to the Fund and that the outcome of the suit should not have any material effect on the operations of any of the Oppenheimer funds.

38 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

BOARD APPROVAL OF THE FUND’S INVESTMENT ADVISORY

AND SUB-ADVISORY AGREEMENTS Unaudited

The Fund has entered into an investment advisory agreement with OFI Global Asset Management, Inc. (“OFI Global” or the “Adviser”), a wholly-owned subsidiary of OppenheimerFunds, Inc. (“OFI” or the “Sub-Adviser”) (“OFI Global” and “OFI” together the “Managers”) and OFI Global has entered into a sub-advisory agreement with OFI whereby OFI provides investment sub-advisory services to the Fund (collectively, the “Agreements”). The Investment Company Act of 1940, as amended, requires that the Board request and evaluate, and that the Managers provide, such information as may be reasonably necessary to evaluate the terms of the Agreements. The Board employs an independent consultant to prepare a report that provides information, including comparative information that the Board requests for that purpose. In addition to in-person meetings focused on this evaluation, the Board receives information throughout the year regarding Fund services, fees, expenses and performance.

The Adviser, Sub-Adviser and the independent consultant provided information to the Board on the following factors: (i) the nature, quality and extent of the Managers’ services, (ii) the comparative investment performance of the Fund and the Managers, (iii) the fees and expenses of the Fund, including comparative fee and expense information, (iv) the profitability of the Managers and their affiliates, including an analysis of the cost of providing services, (v) whether economies of scale are realized as the Fund grows and whether fee levels reflect these economies of scale for Fund investors and (vi) other benefits to the Managers from their relationship with the Fund. The Board was aware that there are alternatives to retaining the Managers.

Outlined below is a summary of the principal information considered by the Board as well as the Board’s conclusions.

Nature, Quality and Extent of Services. The Board considered information about the nature, quality and extent of the services provided to the Fund and information regarding the Managers’ key personnel who provide such services. The Managers’ duties include providing the Fund with the services of the portfolio managers and the Sub-Adviser’s investment team, who provide research, analysis and other advisory services in regard to the Fund’s investments; and securities trading services. OFI Global is responsible for oversight of third-party service providers; monitoring compliance with applicable Fund policies and procedures and adherence to the Fund’s investment restrictions; risk management; and oversight of the Sub-Adviser. OFI Global is also responsible for providing certain administrative services to the Fund as well. Those services include providing and supervising all administrative and clerical personnel who are necessary in order to provide effective corporate administration for the Fund; compiling and maintaining records with respect to the Fund’s operations; preparing and filing reports required by the U.S. Securities and Exchange Commission; preparing periodic reports regarding the operations of the Fund for its shareholders; preparing proxy materials for shareholder meetings; and preparing the registration statements required by federal and state securities laws for the sale of the Fund’s shares. OFI Global also provides the Fund with office space, facilities and equipment.

The Board also considered the quality of the services provided and the quality of the Managers’ resources that are available to the Fund. The Board took account of the fact that the Sub-Adviser has had over fifty years of experience as an investment adviser and

39 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

BOARD APPROVAL OF THE FUND’S INVESTMENT ADVISORY

AND SUB-ADVISORY AGREEMENTS Unaudited / Continued

that its assets under management rank it among the top mutual fund managers in the United States. The Board evaluated the Managers’ advisory, administrative, accounting, legal, compliance services and risk management, and information the Board has received regarding the experience and professional qualifications of the Managers’ key personnel and the size and functions of its staff. In its evaluation of the quality of the portfolio management services provided, the Board considered the experience of Justin Leverenz and Heidi Heikenfeld, the portfolio managers for the Fund, and the Sub-Adviser’s investment team and analysts. The Board members also considered the totality of their experiences with the Managers as directors or trustees of the Fund and other funds advised by the Managers. The Board considered information regarding the quality of services provided by affiliates of the Managers, which the Board members have become knowledgeable about through their experiences with the Managers and in connection with the renewal of the Fund’s service agreements. The Board concluded, in light of the Managers’ experience, reputation, personnel, operations and resources that the Fund benefits from the services provided under the Agreements.

Performance. The Board considered that the Fund does not have a full year of operational history and that its performance could not be a factor in deciding whether to approve the Agreement.

Fees and Expenses of the Fund. The Board reviewed the fees paid to the Adviser and the other expenses borne by the Fund. The Board also considered the comparability of the fees charged and the services provided to the Fund to the fees and services for other clients or accounts advised by the Adviser. The independent consultant provided comparative data in regard to the fees and expenses of the Fund and other retail front-end load diversified emerging markets funds with comparable asset levels and distribution features. After discussions with the Board, the Adviser has agreed to contractually waive fees and/or reimburse the Fund for certain expenses in order to limit “Total Annual Fund Operating Expenses After Fee Waiver and/or Expense Reimbursement” (excluding (i) interest and fees from borrowing, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with generally accepted accounting principles; (ii) expenses incurred directly or indirectly by the Fund as a result of investments in other investment companies, wholly-owned subsidiaries and pooled investment vehicles; (iii) certain other expenses attributable to, and incurred as a result of a Fund’s investments; and (iv) other expenses (including litigation expenses) not incurred in the ordinary course of the Fund’s business) to annual rates of 1.70% for Class A shares, 2.50% for Class C shares, 2.00% for Class R shares, 1.45% for Class Y shares, and 1.25% for Class I shares, as calculated on the daily net assets of the Fund. This contractual fee waiver and/or expense reimbursement may not be amended or withdrawn for one year from the date of the Fund’s prospectus, unless approved by the Board. The Board noted that the Fund’s contractual management fees were lower than its peer group median and higher than its category median. The Board also noted that the Fund’s total expenses were lower than its peer group median and its total expenses, after waivers, were equal to its category median.

Economies of Scale and Profits Realized by the Managers. The Board considered information regarding the Managers’ costs in serving as the Fund’s investment adviser

40 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

and sub-adviser, including the costs associated with the personnel and systems necessary to manage the Fund, and information regarding the Managers’ profitability from their relationship with the Fund. The Board also considered that the Managers must be able to pay and retain experienced professional personnel at competitive rates to provide quality services to the Fund. The Board reviewed whether the Managers may realize economies of scale in managing and supporting the Fund. The Board noted that the Fund currently has management fee breakpoints, which are intended to share with Fund shareholders economies of scale that may exist as the Fund’s assets grow.

Other Benefits to the Managers. In addition to considering the profits realized by the Managers, the Board considered information that was provided regarding the direct and indirect benefits the Managers receive as a result of their relationship with the Fund, including compensation paid to the Managers’ affiliates and research provided to the Adviser in connection with permissible brokerage arrangements (soft dollar arrangements).

Conclusions. These factors were also considered by the independent Trustees meeting separately from the full Board, assisted by experienced counsel to the Fund and to the independent Trustees. Fund counsel and the independent Trustees’ counsel are independent of the Managers within the meaning and intent of the Securities and Exchange Commission Rules.

Based on its review of the information it received and its evaluations described above, the Board, including a majority of the independent Trustees, decided to continue the Agreements through September 30, 2016. In arriving at its decision, the Board did not identify any factor or factors as being more important than others, but considered all of the above information, and considered the terms and conditions of the Agreements, including the management fees, in light of all the surrounding circumstances.

41 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

PORTFOLIO PROXY VOTING POLICIES AND GUIDELINES;

UPDATES TO STATEMENTS OF INVESTMENTS Unaudited

The Fund has adopted Portfolio Proxy Voting Policies and Guidelines under which the Fund votes proxies relating to securities (“portfolio proxies”) held by the Fund. A description of the Fund’s Portfolio Proxy Voting Policies and Guidelines is available (i) without charge, upon request, by calling the Fund toll-free at 1.800.CALL OPP (225.5677), (ii) on the Fund’s website at www.oppenheimerfunds.com, and (iii) on the SEC’s website at www.sec.gov. In addition, the Fund is required to file Form N-PX, with its complete proxy voting record for the 12 months ended June 30th, no later than August 31st of each year. The Fund’s voting record is available (i) without charge, upon request, by calling the Fund toll-free at 1.800.CALL OPP (225.5677), and (ii) in the Form N-PX filing on the SEC’s website at www.sec.gov.

The Fund files its complete schedule of portfolio holdings with the SEC for the first quarter and the third quarter of each fiscal year on Form N-Q. The Fund’s Form N-Q filings are available on the SEC’s website at www.sec.gov. Those forms may be reviewed and copied at the SEC’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330.

Householding—Delivery of Shareholder Documents

This is to inform you about OppenheimerFunds’ “householding” policy. If more than one member of your household maintains an account in a particular fund, OppenheimerFunds will mail only one copy of the fund’s prospectus (or, if available, the fund’s summary prospectus), annual and semiannual report and privacy policy. The consolidation of these mailings, called householding, benefits your fund through reduced mailing expense, and benefits you by reducing the volume of mail you receive from OppenheimerFunds. Householding does not affect the delivery of your account statements.

Please note that we will continue to household these mailings for as long as you remain an OppenheimerFunds shareholder, unless you request otherwise. If you prefer to receive multiple copies of these materials, please call us at 1.800.CALL-OPP (225-5677). You may also notify us in writing or via email. We will begin sending you individual copies of the prospectus (or, if available, the summary prospectus), reports and privacy policy within 30 days of receiving your request to stop householding.

42 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

OPPENHEIMER EMERGING MARKETS INNOVATORS FUND


Trustee and Officers		Brian F. Wruble, Chairman of the Board of Trustees and Trustee
As of 3/1/16		Beth Ann Brown, Trustee
		Matthew P. Fink, Trustee
		Edmund P. Giambastiani, Jr., Trustee
		Elizabeth Krentzman, Trustee
		Mary F. Miller, Trustee
		Joel W. Motley, Trustee
		Joanne Pace, Trustee
		Justin Leverenz, Vice President
		Heidi Heikenfeld, Vice President
		Arthur P. Steinmetz, Trustee, President and Principal Executive Officer
		Cynthia Lo Bessette, Secretary and Chief Legal Officer
		Jennifer Sexton, Vice President and Chief Business Officer
		Mary Ann Picciotto, Chief Compliance Officer and Chief Anti-Money
		Laundering Officer
		Brian S. Petersen, Treasurer and Principal Financial & Accounting Officer

Manager		OFI Global Asset Management, Inc.

Sub-Adviser		OppenheimerFunds, Inc.

Distributor		OppenheimerFunds Distributor, Inc.

Transfer and Shareholder		OFI Global Asset Management, Inc.
Servicing Agent

Sub-Transfer Agent		Shareholder Services, Inc.
		DBA OppenheimerFunds Services

Independent Registered		KPMG LLP
Public Accounting Firm

Legal Counsel		Kramer Levin Naftalis & Frankel LLP

		The financial statements included herein have been taken from the
		records of the Fund without examination of those records by the
		independent registered public accounting firm.

43 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

As an Oppenheimer fund shareholder, you are entitled to know how we protect your personal information and how we limit its disclosure.

Information Sources

We obtain nonpublic personal information about our shareholders from the following sources:

●

Applications or other forms

●

When you create a user ID and password for online account access

●

When you enroll in eDocs Direct, our electronic document delivery service

●

Your transactions with us, our affiliates or others

●

A software program on our website, often referred to as a “cookie,” which indicates which parts of our site you’ve visited

●

When you set up challenge questions to reset your password online

If you visit oppenheimerfunds.com and do not log on to the secure account information areas, we do not obtain any personal information about you. When you do log on to a secure area, we do obtain your user ID and password to identify you. We also use this information to provide you with products and services you have requested, to inform you about products and services that you may be interested in and assist you in other ways.

We do not collect personal information through our website unless you willingly provide it to us, either directly by email or in those areas of the website that request information. In order to update your personal information (including your mailing address, email address and phone number) you must first log on and visit your user profile.

If you have set your browser to warn you before accepting cookies, you will receive the warning message with each cookie. You can refuse cookies by turning them off in your browser. However, doing so may limit your access to certain sections of our website.

We use cookies to help us improve and manage our website. For example, cookies help us recognize new versus repeat visitors to the site, track the pages visited, and enable some special features on the website. This data helps us provide a better service for our website visitors.

Protection of Information

We do not disclose any non-public personal information (such as names on a customer list) about current or former customers to anyone, except as permitted by law.

Disclosure of Information

Copies of confirmations, account statements and other documents reporting activity in your fund accounts are made available to your financial advisor (as designated by you). We may also use details about you and your investments to help us, our financial service affiliates, or firms that jointly market their financial products and services with ours, to better serve your investment needs or suggest financial services or educational material that may be of interest to you. If this requires us to provide you with an opportunity to “opt in” or “opt out” of such information sharing with a firm not affiliated with us, you will receive notification on how to do so, before any such sharing takes place.

Right of Refusal

We will not disclose your personal information to unaffiliated third parties (except as permitted by law), unless we first offer you a reasonable opportunity to refuse or “opt out” of such disclosure.

44 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

Internet Security and Encryption

In general, the email services provided by our website are encrypted and provide a secure and private means of communication with us. To protect your own privacy, confidential and/or personal information should only be communicated via email when you are advised that you are using a secure website. As a security measure, we do not include personal or account information in non-secure emails, and we advise you not to send such information to us in non-secure emails. Instead, you may take advantage of the secure features of our website to encrypt your email correspondence. To do this, you will need to use a browser that supports Secure Sockets Layer (SSL) protocol.

We do not guarantee or warrant that any part of our website, including files available for download, are free of viruses or other harmful code. It is your responsibility to take appropriate precautions, such as use of an anti-virus software package, to protect your computer hardware and software.

●

All transactions, including redemptions, exchanges and purchases, are secured by SSL and 256-bit encryption. SSL is used to establish a secure connection between your PC and OppenheimerFunds’ server. It transmits information in an encrypted and scrambled format.

●

Encryption is achieved through an electronic scrambling technology that uses a “key” to code and then decode the data. Encryption acts like the cable converter box you may have on your television set. It scrambles data with a secret code so that no one can make sense of it while it is being transmitted. When the data reaches its destination, the same software unscrambles the data.

●

You can exit the secure area by either closing your browser, or for added security, you can use the Log Out button before you close your browser.

Other Security Measures

We maintain physical, electronic and procedural safeguards to protect your personal account information. Our employees and agents have access to that information only so that they may offer you products or provide services, for example, when responding to your account questions.

How You Can Help

You can also do your part to keep your account information private and to prevent unauthorized transactions. If you obtain a user ID and password for your account, do not allow it to be used by anyone else. Also, take special precautions when accessing your account on a computer used by others.

Who We Are

This joint notice describes the privacy policies of the Oppenheimer funds, OppenheimerFunds, Inc., each of its investment adviser subsidiaries, OppenheimerFunds Distributor, Inc. and OFI Global Trust Co. It applies to all Oppenheimer fund accounts you presently have, or may open in the future, using your Social Security number—whether or not you remain a shareholder of our funds. This notice was last updated March 2015. In the event it is updated or changed, we will post an updated notice on our website at oppenheimerfunds.com. If you have any questions about this privacy policy, write to us at P.O. Box 5270, Denver, CO 80217-5270, email us by clicking on the Contact Us section of our website at oppenheimerfunds.com or call us at 1.800.CALL OPP (225.5677).

45 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

THIS PAGE INTENTIONALLY LEFT BLANK.

46 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

THIS PAGE INTENTIONALLY LEFT BLANK.

47 OPPENHEIMER EMERGING MARKETS INNOVATORS FUND

LOGO

OppenheimerFunds^®

The Right Way

to Invest

Visit us at oppenheimerfunds.com for 24-hr access to account information and transactions or call us at 800.CALL OPP (800.225.5677) for 24-hr automated information and automated transactions. Representatives also available Mon–Fri 8am-8pm ET.

Visit Us

oppenheimerfunds.com

Call Us

800 225 5677

Oppenheimer funds are distributed by OppenheimerFunds Distributor, Inc.

225 Liberty Street, New York, NY 10281-1008

RS1607.001.0216 April 25, 2016

Item 2. Code of Ethics.

Not applicable to semiannual reports.

Item 3. Audit Committee Financial Expert.

Not applicable to semiannual reports.

Item 4. Principal Accountant Fees and Services.

Not applicable to semiannual reports.

Item 5. Audit Committee of Listed Registrants

Not applicable.

Item 6. Schedule of Investments.

a) Not applicable. The complete schedule of investments is included in Item 1 of this Form N-CSR.

b) Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 10. Submission of Matters to a Vote of Security Holders.

The Fund’s Governance Committee Provisions with Respect to Nominations of Directors/Trustees to the Respective Boards

None

Item 11. Controls and Procedures.

Based on their evaluation of the registrant’s disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940 (17 CFR 270.30a-3(c)) as of 2/29/2016, the registrant’s principal executive officer and principal financial officer found the registrant’s disclosure controls and procedures to provide reasonable assurances that information required to be disclosed by the registrant in the reports that it files under the Securities Exchange Act of 1934 (a) is accumulated and communicated to registrant’s management, including its principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure, and (b) is recorded, processed, summarized and reported, within the time

periods specified in the rules and forms adopted by the U.S. Securities and Exchange Commission.

There have been no changes in the registrant’s internal controls over financial reporting that occurred during the registrant’s second fiscal quarter of the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12. Exhibits.


(a)	(1)	Not applicable to semiannual reports.

	(2)	Exhibits attached hereto.

	(3)	Not applicable.

(b)	Exhibit attached hereto.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Oppenheimer Emerging Markets Innovators Fund



By:		/s/ Arthur P. Steinmetz
		Arthur P. Steinmetz
		Principal Executive Officer
Date:		4/15/2016

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


By:		/s/ Arthur P. Steinmetz
		Arthur P. Steinmetz
		Principal Executive Officer
Date:		4/15/2016
By:		/s/ Brian S. Petersen
		Brian S. Petersen
		Principal Financial Officer
Date:		4/15/2016